Recently, we demonstrated that there is a significant increase in tryptase-positive mast cells and CD68-positive TAMs, as well as a significant increase in MVD and a positive correlation in chemo-resistant non-responder when compared with chemo-sensitive responder DLBCL patients (Figure 1) [112]. Here, CD68 is linked to diffuse large B-cell lymphoma.